Early Efficacy of Ferric Carboxymaltose (Ferinject®) in Patients with Iron-Deficiency Anemia: Single Institution Experience

被引：0
|
作者：
Kerbage, Fouad [1 ,2 ,3 ]
Sakr, Riwa [2 ,3 ]
Akoury, Elie [2 ,3 ]
Eid, Anthony [2 ,3 ]
Chahine, Georges [2 ,3 ]
Massoud, Marcel [2 ,3 ]
机构：
[1] Inst Gustave Roussy, Hematol Dept, Villejuif, France
[2] Holy Spirit Univ Kaslik, Jounieh, Lebanon
[3] UHC Notre Dame Secours, Jbeil, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Ferric Carboxymaltose; Early Efficacy; Iron Deficiency Anemia;
D O I：
10.1016/j.clml.2018.07.245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-056
引用
下载
收藏
页码：S296 / S297
页数：2
相关论文
共 50 条
  • [31] Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia
    Basha, Ahmed
    Izham, Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdulla, Mohammad Abdul-Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmed A.
    Shwaylia, Hawraa M.
    Ekeibed, Yeslem Mohamed Aly
    AbuMousa, Rami
    Yassin, Mohamed A.
    BLOOD, 2020, 136
  • [32] An audit comparing a new intravenous (IV) iron preparation, ferric carboxymaltose (Ferinject) to IV iron dextran (Cosmofer) for the treatment of iron-deficiency anaemia in pregnancy
    Myers, B.
    Myers, O. J.
    Moore, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 30 - 30
  • [33] Ferric carboxymaltose: a guide to its use in iron-deficiency anaemia
    Drugs & Therapy Perspectives, 2010, 26 (1) : 1 - 4
  • [34] Ferric Carboxymaltose A Review of its Use in Iron-Deficiency Anaemia
    Lyseng-Williamson, Katherine A.
    Keating, Gillian M.
    DRUGS, 2009, 69 (06) : 739 - 756
  • [35] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Bernd Froessler
    Tijana Gajic
    Gustaaf Dekker
    Nicolette A. Hodyl
    Archives of Gynecology and Obstetrics, 2018, 298 : 75 - 82
  • [36] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Ibrahim A. Abdelazim
    Bassam Nusair
    Shikanova Svetlana
    Gulmira Zhurabekova
    Archives of Gynecology and Obstetrics, 2018, 298 : 1231 - 1232
  • [37] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Froessler, Bernd
    Gajic, Tijana
    Dekker, Gustaaf
    Hodyl, Nicolette A.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (01) : 75 - 82
  • [38] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Abdelazim, Ibrahim A.
    Nusair, Bassam
    Svetlana, Shikanova
    Zhurabekova, Gulmira
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (06) : 1231 - 1232
  • [39] Ferric Carboxymaltose: Efficacy and Safety in Patients With Gastrointestinal-Related Iron Deficiency Anemia: A Pooled Analysis
    Lichtenstein, Gary R.
    He, Andy
    Hanauer, B.
    Keshav, Satish
    Onken, Jane E.
    GASTROENTEROLOGY, 2014, 146 (05) : S369 - S369
  • [40] Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
    Wolf, Myles
    Rubin, Janet
    Achebe, Maureen
    Econs, Michael J.
    Peacock, Munro
    Imel, Erik A.
    Thomsen, Lars L.
    Carpenter, Thomas O.
    Weber, Thomas
    Brandenburg, Vincent
    Zoller, Heinz
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (05): : 432 - 443
12345